Bio and Archives
Karl Thiel joined the Motley Fool Rule Breakers team in January 2005. He found his way to Fooldom from Murphy Investment Management, where he gave investment advice and was co-portfolio manager of a small biotech mutual fund. Prior to that, Karl started online magazines for erstwhile bioinformatics company DoubleTwist and for the popular biotech portal Biospace.com.
He still keeps his hand in the science writing game as a frequent contributor to Nature Biotechnology. Karl's rants and ramblings on the biotech industry have also shown up in such unexpected places as The New York Times, the San Francisco Chronicle, the Seattle Times, Forbes, Genomics & Proteomics, Helix, and elsewhere. He was also a contributing author to From Alchemy to IPO: The Business of Biotechnology, by Cynthia Robbins-Roth.
Karl never went to journalism school, but he did once swim in Bob Woodward's pool. He lives with his wife and daughter in Portland, Ore., a city where he has resided for six years but never sought work. If you're ever lost in the woods with him, take comfort in the fact that he knows how to identify edible mushrooms. Pour him a glass of pinot noir, and he may even cook some for you.